Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists

Chemotherapy is used to treat numerous cancers including melanoma. However, its effectiveness in clinical settings is often hampered by various mechanisms. Previous studies have demonstrated that prooxidative stressor-mediated generation of oxidized lipids with platelet-activating factor-receptor (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Ravi P., Ferracini, Matheus, Travers, Jeffrey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398925/
https://www.ncbi.nlm.nih.gov/pubmed/25922565
http://dx.doi.org/10.1155/2015/820543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398925/
https://www.ncbi.nlm.nih.gov/pubmed/25922565
http://dx.doi.org/10.1155/2015/820543

Ejemplares similares